What You Should Know:
– NVIDIA launched the UK’s fastest supercomputer — Cambridge-1, the world’s first collaborative, industry-wide system dedicated to accelerating healthcare and digital biology research using powerful combination of AI and simulation.
– At the virtual inauguration, NVIDIA CEO and founder Jensen Huang discussed what NVIDIA’s $100 million investment will mean for the UK. He said the system will enable research breakthroughs at a scale and speed previously impossible with global impact potentially benefiting millions.
Its first projects with AstraZeneca, GSK, Guy’s and St Thomas’ NHS Foundation Trust, King’s College London and Oxford Nanopore Technologies include developing a deeper understanding of brain diseases like dementia, using AI to design new drugs and improving the accuracy of finding disease-causing variations in human genomes.
Cambridge-1 is the first NVIDIA supercomputer designed and built for external research access. The company will collaborate with researchers to make much of this work available to the greater scientific community.
Featuring 80 DGX™ A100 systems integrating NVIDIA A100 GPUs, BlueField®-2 DPUs and NVIDIA HDR InfiniBand networking, Cambridge-1 is an NVIDIA DGX SuperPOD that delivers more than 400 petaflops of AI performance and 8 petaflops of Linpack performance. The system is located at a facility operated by NVIDIA partner Kao Data.
Cambridge-1 is the first supercomputer NVIDIA has dedicated to advancing industry-specific research in the U.K. The company also intends to build an AI Center for Excellence in Cambridge featuring a new Arm-based supercomputer, which will support more industries across the country.